Aquestive Therapeutics (AQST) Assets: 2017-2025
Historic Assets for Aquestive Therapeutics (AQST) over the last 8 years, with Sep 2025 value amounting to $163.6 million.
- Aquestive Therapeutics' Assets rose 48.75% to $163.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $163.6 million, marking a year-over-year increase of 48.75%. This contributed to the annual value of $101.4 million for FY2024, which is 76.64% up from last year.
- Per Aquestive Therapeutics' latest filing, its Assets stood at $163.6 million for Q3 2025, which was up 74.56% from $93.7 million recorded in Q2 2025.
- In the past 5 years, Aquestive Therapeutics' Assets ranged from a high of $163.6 million in Q3 2025 and a low of $51.8 million during Q3 2022.
- For the 3-year period, Aquestive Therapeutics' Assets averaged around $95.7 million, with its median value being $101.4 million (2024).
- In the last 5 years, Aquestive Therapeutics' Assets spiked by 111.35% in 2024 and then dropped by 21.07% in 2025.
- Over the past 5 years, Aquestive Therapeutics' Assets (Quarterly) stood at $62.0 million in 2021, then dropped by 7.94% to $57.1 million in 2022, then grew by 0.61% to $57.4 million in 2023, then surged by 76.64% to $101.4 million in 2024, then skyrocketed by 48.75% to $163.6 million in 2025.
- Its Assets stands at $163.6 million for Q3 2025, versus $93.7 million for Q2 2025 and $102.2 million for Q1 2025.